Gilead Sciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $6.37B | $1.27B |
| FY2010 | — | $5.86B | $907.9M |
| FY2011 | $7.61B | $6.74B | $9.88B |
| FY2012 | $7.05B | $9.30B | $1.80B |
| FY2013 | $3.94B | $11.37B | $2.11B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2009 | — | $6.37B | $1.27B |
| FY2010 | — | $5.86B | $907.9M |
| FY2011 | $7.61B | $6.74B | $9.88B |
| FY2012 | $7.05B | $9.30B | $1.80B |
| FY2013 | $3.94B | $11.37B | $2.11B |